Delivery Order SPE2DB24D2011-SPE2DB25FBRUJ
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $79K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 13, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $60,644.38. The contract carries a firm fixed price structure with an ultimate completion date of August 14, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Otezla 30 mg tablets in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $11,440.33 and is scheduled for completion by September 10, 2025. The contract was competitively awarded with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a firm fixed price delivery order from the Defense Logistics Agency's Medical Supply Chain for Otezla 30 mg tablets (60-count units) valued at $35,634.81. This non-set-aside, competitively awarded contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The order represents a standard pharmaceutical supply delivery executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Otezla 30 mg tablets (60-count units) valued at $34,867.15. The contract, which is not designated as a set-aside, carries a firm fixed price structure with an ultimate completion date of August 20, 2025. This delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $33,358.49 by the Defense Logistics Agency (DLA) for the supply of Otezla 30 mg tablets in quantities of 60. The contract is structured as a firm fixed price delivery order with a completion date of September 2, 2025, and was competitively awarded without set-aside provisions on August 29, 2025. Performance will be executed at the company's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 29, 2025, valued at $2,623.24 for the supply of Otezla 30 mg tablets (60-count units) to the Defense Logistics Agency. The contract utilizes a firm fixed price model with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $27,320.78. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Otezla 30 mg tablets in a quantity of 60 units, with a contract ceiling value of $7,352.82. This award represents a firm fixed price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $31,530.56 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Otezla 30 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 28, 2025. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $13,321.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count packages) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The pharmaceutical distributor, headquartered in...